Impact_of_two_cycles_of_preoperative_chemotherapy_with_intraarterial_cisplatin_and_intravenous_doxorubicin_on_the_choice_of_surgical_procedure_for_high-grade_bone_sarcomas_of_the_extremities._The_authors_assessed_the_impact_of_two_cycles_of_preoperative_chemotherapy_(POCT)_with_intraarterial_cisplatin_(120_mg/m2)_and_continuous_intravenous_doxorubicin_hydrochloride_(Adriamycin;_20_mg/m2/day_x_3_days)_on_the_decision_to_perform_a_limb-sparing_procedure_(LSP)_or_amputation_in_22_patients_with_high-grade_bone_sarcomas_of_the_extremities._The_tumor_types_were_osteosarcoma_(17),_malignant_fibrous_histiocytoma_(three),_leiomyosarcoma_(one),_and_malignant_schwannoma_(one)._Surgical_stages_were_IIA_(three),_IIB_(17),_and_IIIB_(two)._The_prechemotherapy_surgical_options_chosen_were_12_amputations_(55%_of_patients)_and_ten_LSPs_(45%)._The_initial_decisions_to_amputate_were_based_on_a_combination_of_the_following:_improper_biopsy_(five_cases),_large_tumors_(ten)_and_those_with_neurovascular_encroachment_(six),_and_pathological_fracture_(one)._Following_chemotherapy,_18_LSPs_(81%)_and_four_amputations_(19%)_were_performed._Nine_of_12_patients_(75%)_initially_deemed_unresectable_were_converted_to_LSP._The_median_tumor_response_(necrosis;_range,_0%-100%)_was_70%;_ten_of_22_specimens_had_necrosis_greater_than_95%._Median_tumor_necrosis_for_the_patients_treated_by_amputation_and_LSPs_was_45%_and_88%,_respectively._Following_surgery,_all_patients_received_four_additional_cycles_of_cisplatin_and_doxorubicin._The_median_follow-up_period_is_30_months;_six_patients_have_developed_metastatic_disease,_with_a_median_disease-free_interval_of_16.6_months._The_rate_of_local_tumor_control_is_95%_(21_of_22_patients).